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Pyruvate carboxylase (PC) is an anaplerotic enzyme that catalyzes the carboxylation of py-
ruvate to oxaloacetate, which is crucial for replenishing tricarboxylic acid cycle intermedi-
ates when they are used for biosynthetic purposes. We examined the expression of PC by
immunohistochemistry of paraffin-embedded breast tissue sections of 57 breast cancer pa-
tients with different stages of cancer progression. PC was expressed in the cancerous
areas of breast tissue at higher levels than in the non-cancerous areas. We also found sta-
tistical association between the levels of PC expression and tumor size and tumor stage
(P < 0.05). The involvement of PC with these two parameters was further studied in four
breast cancer cell lines with different metastatic potentials; i.e., MCF-7, SKBR3 (low metas-
tasis), MDA-MB-435 (moderate metastasis) and MDA-MB-231 (high metastasis). The abun-
dance of both PC mRNA and protein in MDA-MB-231 and MDA-MB-435 cells was 2-3-fold
higher than that in MCF-7 and SKBR3 cells. siRNA-mediated knockdown of PC expression
in MDA-MB-231 and MDA-MB-435 cells resulted in a 50% reduction of cell proliferation, mi-
gration and in vitro invasion ability, under both glutamine-dependent and glutamine-deplet-
ed conditions. Overexpression of PC in MCF-7 cells resulted in a 2-fold increase in their
proliferation rate, migration and invasion abilities. Taken together the above results suggest
that anaplerosis via PC is important for breast cancer cells to support their growth and
motility.
Introduction
As a result of over-stimulation by growth factor signaling, most tumors adapt their metabolism
in order to accommodate both energy and structural component needs during rapid prolifera-
tion [1]. Unlike differentiated cells, regardless of the presence of oxygen, most tumors
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metabolize glucose via anaerobic glycolysis known as the ‘Warburg effect’ [2,3,4]. As the result
of this metabolic shift, tumors consume large amounts of glucose, causing the accumulation of
lactate. The enhanced glucose utilization via anaerobic glycolysis partly results from the over-
expression of c-myc and hypoxia inducible factor-1α (HIF1α), which in turn stimulates expres-
sion of hexokinase II, lactate dehydrogenase (LDH), and the pyruvate kinase M2 isoform
(PK-M2) that enhance glycolysis, and pyruvate dehydrogenase kinase (PDK) that can inhibit
the oxidative decarboxylation of pyruvate by phosphorylation of pyruvate dehydrogenase. This
phenomenon results in channeling of pyruvate into anaerobic glycolysis and limits its entry
into mitochondria for oxidative phosphorylation and also shifts mitochondrial metabolism to-
wards biosynthetic purposes [5,6,7,8]. Anaplerosis via pyruvate carboxylation and glutamate
synthesis from glutamine (glutaminolysis) are the two major biochemical reactions which re-
plenish TCA cycle intermediates withdrawn for biosynthetic pathways [9]. Furthermore, up-
regulation of expression by c-myc of glutaminase, an enzyme which converts glutamine to glu-
tamate is also observed in many tumors [10,11,12,13]. This high demand for glutamine is a
hallmark of most tumors and was proposed as a target of cancer treatment. While growing evi-
dence have now indicated that glutaminolysis is crucial for many cancers, limited information
is available regarding the importance of pyruvate carboxylation via pyruvate carboxylase (PC)
in cancers.
Fan et al. [14] have shown that over-expression of PC mRNA and protein was detected in
solid cancerous lung tissue. 13C Isotopomer-based metabolomic analysis reveals that pyruvate
carboxylation flux is increased in the cancerous lung tissue compared to the paired non-cancer-
ous lung tissues, suggesting that anaplerosis via pyruvate carboxylation is essential to fulfill the
high anabolic demand of lung tumor during the establishment of primary tumorigenesis. By
infusing 13C-labeled glucose or 15N-labeled glutamine in the patients with early-stage non-
small cell lung cancer before tissue resection, the same group of investigator showed that the la-
beled glucose enters mitochondrial metabolism via pyruvate carboxylation while this not the
case for 15N-glutamine, indicating that anapleorosis via PC is the preferred route in non-small
cell lung cancer [15]. Furthermore suppression of PC expression in non-small cell lung cancer
cell lines resulted in the retardation of cell growth primarily due to the disruption of biosynthe-
sis of lipid and nucleotide and imbalance of glutathione metabolism [15].
PC is also involved in brain tumor progression. Interestingly, many low grade glioblastomas
possess a defect in the cytosolic isocitrate dehydrogenase (IDH1) which functions in converting
isocitrate to α-ketoglutarate concomitant with the production of NADPH. The α-ketoglutarate
once formed in the cytoplasm by IDH1 can re-enter mitochondria and be used for various bio-
synthetic pathways [16]. Mutation of IDH1 is predicted to impair mitochondrial metabolism
in many cancers [17]. Izquierdo-Garcia et al [18] have recently engineered astrocytes to meta-
bolically mimic low grade glioblastomas by expressing mutated IDH1 and found that these
astrocytes bearing an IDH1 mutation bypass the IDH1 defect by up-regulating pyruvate car-
boxylation. In supporting this finding, Cheng et al. [19] have demonstrated that PC is highly
abundant in some glioblastoma cell lines, and is required to support its growth under gluta-
mine-independent conditions. The above evidence highlights the roles of PC in supporting the
growth of lung and brain tumors.
Although PC has been shown to be highly abundant in these two types of tumor and ap-
pears to support growth of glioblastoma under glutamine-independent growth, it remains un-
clear whether PC is highly expressed in other types of cancer and is also required to support
other aggressive phenotypes. Here we show that PC is overexpressed in breast cancer tissues,
and that the level of expression is correlated with tumor size and stage. We also demonstrate
that suppression of PC expression in a highly metastasized cell line, MDA-MB-231 markedly
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reduces its proliferation, migration and in vitro invasion ability, indicating the importance of
PC to support growth and invasion of breast cancer.
Materials and Methods
Cell culture
Human breast cancer cell lines, MCF-7 (ATCC:HTB22) [20] and MDA-MB-231(ATCC:
HTB26) [21], MDA-MB-435 (ATCC:HTB129) and SKBR3 (ATCC: HTB-30) were grown in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with 10% (v/v) fetal bo-
vine serum (FBS). The cells were maintained at 37°C with 5% CO2. The glutamine-independent
MDA-MB-231 cell line was established by progressive depletion of glutamine in the culture
medium from 4 mM to 0 mM. In brief, cells were grown in DMEM supplemented with 2 mM
glutamine for 2 weeks, 1 mM for 2 weeks, 0.5 mM for 2 weeks and no glutamine, respectively.
After 1 month of growing this cell line in the absence of glutamine, it was used for subsequent
experiments.
siRNA transfection of and overexpression of PC
6 x 105cells of MDA-MB-231 cells or 3.5 x 105cells of MDA-MB-435 were plated in 35-mm
dish containing 2 ml of DMEM supplemented with 10% (v/v) FBS and maintained at 37°C
with 5% CO2 for 24 h. 50 pmole (25 nM) or 100 pmole (50 nM) of siRNA targeted to human
PC (Cat.no. 4390824, Ambion) were transfected to MDA-MB-231 or MDA-MB-435, respec-
tively using Lipofectamine 2000 transfection reagent (Invitrogen) in the Optimem-reduced
serum medium (Invitrogen). Same amounts of scrambled control siRNA were also transfected
to both cell lines. The transfected cells were maintained in 2 ml complete medium for 2 days.
The cells were subsequently harvested for RT-PCR andWestern blot analyses.
MCF-7 cells overexpressing PC were generated by transfection of plasmid encoding human
PC (pEF-PC) [22]. In brief, 2 x 105 cells of MCF-7 were plated in 2 ml complete DMEMmedi-
um in 35 mm-dish 24 h before transfecting with 4 μg of pEF-PC plasmid. Upon 48 h post-
transfection, the stable MCF-7 cells overexpressing PC cells were selected with 0.5 μg/mL puro-
mycin for one week. The stable lines were expanded for another week before proliferation, mi-
gration and invasion assays were performed.
Reverse transcription polymerase chain Reaction (RT-PCR)
Total RNA was extracted from cells using TRIzolReagent (Gibco) following the manufacturer’s
instructions. Initially the random hexamers-primed RNA was carried out in a 10 μl-reaction
mixture containing 2 μg of total RNA and 200 ng of random hexamers (Promega) at 70°C for
5 min, before being chilled at 4°C. Reverse transcription was initiated by adding 10 μl of mix-
ture containing 1xImProm-II reaction buffer, 3 mMMgCl2, 0.5 mM dNTP mix and 160 units
of ImProm-II reverse transcriptase (Promega), to the primed-RNA mixture and the reaction
was incubated at 25°C for 5 min, 42°C for 60 min and 70°C for 15 min, respectively. The cDNA
was stored at -20°C until used.
Quantitative real-time PCR
Quantitative real time PCR was performed in a 12 μl-reaction mixture containing 6 μl of
2xKAPA probe Fast qPCRmaster mix Universal (KAPA Biosystems), 2 μl of cDNA, 1 μM of
forward and reverse primers and 0.5 μM of fluorogenic probe as described previously [23]. The
thermal profiles consisted of initial incubation at 50°C for 2 min and 95°C for 10 min followed
by 40 cycles of denaturation at 95°C for 15 sec and annealing/extension at 60°C for 1 min in
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Mx3000P Q- PCR system (Agilent Technologies). To identify the PC mRNA isoforms ex-
pressed in breast cancer cell lines, quantitative real time PCR was performed in a 20 μl-reaction
mixture containing 10 μl of 2x KAPA SYBR FAST qPCR Master mix universal (KAPA Biosys-
tems), 200 nM each of specific forward primer for detecting each isoform of PC mRNA and re-
verse primers [24], and 2 μl of cDNA. The thermal profiles consisted of initial incubation at
95°C for 10 min followed by 40 cycles of denaturation at 95°C for 30 sec, annealing at 60°C for
30 sec and extension at 72°C for 30 sec in Mx 3000P Q- PCR systems (Agilent Technologies).
Expression of PC mRNA was normalized with that of 18s ribosomal RNA gene, and was
shown as the relative gene expression. Fold change was calculated using the comparative CT
method (ΔΔCT method) [25].
Western blot analysis
MCF-7, MDA-MB-231 and MDA-MB435 cells grown in T75 cm2 flask were trypsinized with
0.05% (v/v) trypsin-EDTA. The detached cells were centrifuged at 3,000 xg for 5 min, cell pellet
was re-suspended in 150 μl of RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mMNaCl, 1 mM
EDTA, 0.25% sodium deoxycholate, 1% (v/v) NP-40 and 1x protease inhibitor cocktail
(Roche). 70 μg of protein lysate were subjected to discontinuous SDS-PAGE [26] under reduc-
ing conditions. The proteins were transferred to a polyvinylidenedifluoride (PVDF) membrane
by Semi-Dry Transfer Cell (BIO-RAD) for 1.5 h. The membrane was incubated in 15 ml of
blocking solution [5% (w/v) skim milk in 1% (v/v) Tween 20 in PBS-T] at 4°C overnight. For
detecting PC protein, the blot was incubated with1:5,000 dilution of rabbit anti-chicken PC
polyclonal antibody [27] for 2 h. The blot was briefly washed in PBS-T before incubating with
1:5,000 dilution of goat anti-rabbit IgG conjugated with horseradish peroxidase (HRP)
(DAKO) for 1 h. For detection of β-actin, mouse anti-actin monoclonal antibody (sc-8432)
(Santa Cruz) and sheep anti-mouse IgG conjugated with HRP (GE healthcare) were used for
primary and secondary antibodies, respectively. The immunoreactive bands were detected
using an enhanced chemiluminescence substrate (Perkin Elmer). The images were captured
using Chemiluminescence Imaging System (Syngene).
Proliferation assay
Cell proliferation was determined by counting the viable cells for 7 days. At 48 h post-transfec-
tion, the 1 x 105 cells of MDA-MB-231, MDA-MB-435 or MCF-7 overexpressing PC were plat-
ed into 35 mm dishes and grown in the absence or presence of 4 mM glutamine for 1, 2, 3, 4, 5,
6 and 7 days, at 37°C in CO2 incubator. At each time point, the cells were trypsinized, stained
with 0.4% trypan blue and counted under a microscope. The results are presented as means +
standard deviations of two independent experiments.
Wound healing assay
1.5 x 105 cells of MDA-MB-231, MDA-MB-435 and MCF-7 overexpressing PC were replated
in 24-well plate in DMEM containing no serum overnight before the artificial wound was gen-
erated by scratching the monolayer with a pipette tip. The wound’s closure (width) of the PC
knockdown at 0 and 48 h was measured and shown as the mean + standard deviation of that of
the scrambled control which was arbitrarily set as 100%.
In vitro invasion assay
In vitro invasion assays were performed by plating 1.2 x 105 of MDA-MD-231, MDA,
MDA-MB-435 or MCF-7 cells in 200 μl of serum-free medium containing 4 mM or 0 mM
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glutamine into the upper chamber of Transwell (6.5-mm diameter polyvinylpyrrolidone-free
polycarbonate filter of 8-μm pore size) (Corning, NY, USA) which was pre-coated with
20 μg Matrigel (BD Biosciences) while the lower chamber contained medium supplemented
with 10% (v/v) FBS for 4 h (for MDA-MB-231) or with 20% FBS for 24 h (for MCF7 and
MDA-MB-435) at 37°C. The non-invaded cells in the upper compartment were removed and
the chamber was washed twice with 1x PBS. The cells that had invaded through the matrix
were fixed with 4% (v/v) paraformaldehyde in 1x PBS for 20 min and stained with 0.5% crystal
violet in 25% (v/v) methanol overnight, followed by two washes with tap water. Finally, the in-
vaded cells were counted under a microscope and the percentage of invasion was compared
with that of the scrambled control cell which was arbitrarily set as 100%.
Immunohistochemistry (IHC)
Fifty-seven paraffin-embedded breast cancer tissue sections were collected under the protocols
approved by Siriraj Institute Revision Board, Faculty of Medicine Siriraj Hospital, Mahidol
University (COA no. Si 230/2014), and all clinical investigation were conducted according to
the principles expressed in the Declaration of Helsinki. The written informed consent was ob-
tained from each participant who enrolled in the study. Those breast tissues were diagnosed in-
vasive ductal carcinoma. Firstly, the antigen was retrieved by incubation with 10 mM citrate
buffer pH 6 at 95°C for 1 h. The sections were blocked with 2% (w/v) BSA for 20 min before in-
cubating with 1:1,000 dilution of anti-chicken PC antibody [27] at room temperature over-
night. Excess primary antibody was removed by washing with 1x PBS for 10 min before
incubating with specific anti-rabbit EnVision+system-HRP labelled polymer (DAKO) at room
temperature for 30 min. The secondary antibody was washed with 1x PBS for 10 min before
0.05% (w/v) 3,3’-diaminobenzidine (DAB) solution was applied to the sections and incubated
at room temperate for 5 min. The sections were counter-stained with Mayer’s hematoxylin,
dipped in 1% (w/v) lithium carbonate and washed with tap water for 5 min. Finally, the sec-
tions were mounted with Permount and examined under the microscope. PC expression was
semi-quantitatively scored on the basis of percentage of PC-positive cells and the immunos-
taining intensity. Grading for the percentage of PC-positive cancer cells were as follows: 1 for
1–25%; 2 for 26–50%; 3 for 51–75% and 4 for 76–100%. The intensities of PC staining in cancer
tissues were as follows: 0, unstained; 1, slightly; 2, intermediate and 3, strongest staining. The
interpretation of PC expression was performed by the scores of the percent positive cells (1–4)
multiplied by the scores of staining intensity (0–3) to reach the total final immunohistochemis-
try (IHC) score of 0–12. The results were then categorized as follows; low expression, IHC
score 6; and high expression, IHC score> 6. All samples were anonymous and independent-
ly scored by two investigators of whom one is a pathologist.
Statistical analysis
All values were expressed as mean ± standard deviations. The statistical analysis was performed
using Student’s t-test, two way anova and univariate analysis where  P< 0.05,  P< 0.01 and
 P value< 0.001.
Results
PC was overexpressed in breast cancer tissues and correlated with
tumor size and late stage of tumor progression
A previous study has reported the overexpression of PC in solid lung tumor tissue [14]. To ex-
amine whether this was the case for breast cancer, we performed immunohistochemistry
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(IHC) staining using an anti-PC antibody on breast tissue sections collected from 57 patients
who had stages I-IV of breast cancer using anti-PC antibody. In contrast to the non-cancerous
area of the tissue sections, (Fig 1A), PC was highly expressed in the cancerous areas of the
breast tissues (Fig 1B). The expression levels of PC expression also varied in different stages of
cancer (Fig 1C–1F). Expression of PC in stromal fibroblasts and infiltrating immune cells was
rarely observed.
PC expression was detected in breast tissues of most cancer patients (96% of the total stud-
ied cases) except two cases which were stage I. Overall, 72% of breast cancer tissues showed a
low expression level of PC whereas 28% had a high expression level of PC (Table 1). Based on
grouping the patients into early stage without distant metastasis (stages I-III) and late stage
with distant metastasis (stage IV), 67% (4 in 6 cases) of breast cancer with distant metastasis
showed a high expression level of PC. In contrast, only 24% (12 in 51 cases) of patients without
Fig 1. Immunohistochemistry staining of PC in paraffin-embedded breast tissue sections of patients with various stages of breast cancer. (A)
Normal adjacent area of breast tissue showing weak staining of PC compared to strong staining in the cancerous area (B) of the same tissue. The
representative samples showing different expression levels of PC in different stages of breast cancer: (C) stage 1, (D) stage 2, (E) stage 3 and (F) stage 4.
Original magnification, 100x.
doi:10.1371/journal.pone.0129848.g001
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metastasis had a high level of PC expression. Univariate analysis showed a significant correla-
tion between PC expression level and stage IV (P = 0.046). Interestingly, PC expression showed
a significant correlation with the tumor size (Table 1) (P = 0.033) i.e., PC was poorly expressed
in most tumor cases with small volume (<4 cm3) (86%, 25/29). The other clinicopathological
parameters including histological type, invasion, estrogen receptor (ER), progesterone receptor
(PR) and HER2 expression did not show statistical associations with PC expression.
PC is highly abundant in metastasized breast cell lines, MDA-MB-231
and MDA-MB-435
Because the degree of PC expression showed statistical association with tumor size and stage,
we hypothesized that PC was required to support tumor growth and invasion of breast cancer
cells. We examined the above hypothesis by investigating the expression levels of PC in breast
cancer cell lines with different degrees of motility, namely, MCF-7, SKBR3, MDA-MB-435 and
MDA-MB-231. As shown in Fig 2A, the motilities of MDA-MB-435 and MDA-MB-231 are
10-fold and 75-fold higher than those of MCF-7 and SKBR3 cells, respectively. Consistent with
the motility phenotype, MCF-7 and SKBR3 cell lines possess low expression level of PC mRNA
while MDA-MD-231 and MDA-MB-435 cell lines express PC mRNA 4-fold and 2-fold higher
than MCF-7 (Fig 2B). The two alternative PC mRNA isoforms, namely variant 1 and variant 2
which differ in their 5’-untranslated regions, are differentially transcribed from two alternative
Table 1. Univariate analysis of expression level of PC in breast tissues and clinicopathological parameters.
Variable (Total cases) PC expression (IHC score) P-value
No of case Low (< 6) High (> 6)
Tumor volume (cm3) (52)
< 4 28 24 4 0.033*
> 4 24 14 10
Tumor staging (57)
I 18 15 3 0.225
II 22 17 5 0.555
III 11 7 4 0.482
IV 6 2 4 0.046*
Histological type (56)
Well-differentiated 7 6 1 0.661
Moderately-differentiated 30 20 10 0.365
Poorly-differentiated 19 15 4 0.543
Invasion (57)
Absence 24 18 6 0.769
Presence 33 23 10
ER (57)
High (4) 38 29 9 0.356
Low (0–3+) 19 12 7
PR (57)
High (4) 17 14 3 0.342
Low (0–3+) 40 27 13
HER2 (57)
Negative 37 27 10 1.00
Positive 20 14 6
doi:10.1371/journal.pone.0129848.t001
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Fig 2. Migration ability of various breast cancer cell lines and the expression levels of PC in these cell lines. A, Migration ability of SKBR3, MCF-7,
MDA-MB-435 and MDA-MB-231. B, Q-PCR analysis of PC mRNA expression in the above cell lines. The expression of PC was normalized with the
expression of 18s rRNA gene and shown as the relative gene expression. The relative PC expression in MCF-7 was arbitrarily set as 1. C, Real time PCR
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promoters, the distal and the proximal promoters, respectively [24]. To examine which of these
two PC mRNA isoforms was up-regulated in MDA-MB-231 and MDA-MB-435 cells, quanti-
tative real-time PCR using primers specific for variants 1 and 2 was performed. As shown in
Fig 2C, expression of variant 1 was up-regulated in all cell lines however both MDA-MB-231
and MDA-MB-431 possessed expression of variant 1 more than MCF-7 and SKBR3.
Western blot analysis of PC protein of these four cell lines was also consistent with their mo-
tility phenotype and PC mRNA expression i.e. the abundance of PC in MDA-MB-231 and
MDA-MB-435 are 4.5-fold higher than in MCF-7 and SKBR3 (Fig 2D and 2E).
Suppression of PC expression lowers growth, migration and invasion
ability of highly metastasized breast cancer cell lines
We next examined whether overexpression of PC in the MDA-MB-231 cell line was necessary
to support its growth and invasion ability. We suppressed expression of PC in this cell line by
siRNA and assessed the phenotypes of the knockdown cells. As shown in Fig 3A and 3B, sup-
pression of PC expression in MDA-MB-231 resulted in 90% and 80% decreases in PC mRNA
and PC protein levels, respectively. PC knockdown MDA-MB-231 cell line did not affect prolif-
eration in the first day but showed a 50% reduction in growth by day 2 (Fig 4A). Similar de-
grees of reduction were observed until day 7. Real-time PCR analysis also confirmed that the
retarded proliferation rate of this cell line was accompanied by suppression of PC mRNA
throughout day 7 (Fig 4B). Because suppression of PC expression did not completely inhibit
the cell proliferation rate, the ability of the PC knockdown MDA-MB-231 cells to grow in the
complete growth medium may have resulted from the compensation of anaplerosis via gluta-
minolysis. To examine whether this latter pathway contributes to the survival of the PC knock-
down cells, the glutamine-independent PC deficient MDA-MB-231 cell line was generated. In
analysis of PC mRNA variant 1 and 2 expression in the above cell lines. The expression of PC was normalized with the expression of 18s rRNA gene and
shown as the relative gene expression. The expression of the relative PCmRNA variants in MCF-7 was arbitrarily set as 1.D, Western blot analysis of PC
protein in the above cell lines. The blot was also probed with anti-actin antibody to serve as loading control. E, The immunoreactive band intensity of PC in D
was quantitated and normalized with that of the β-actin and shown as the relative PC expression. The statistical analysis was conducted using student’s t-test
where *P < 0.05, **P < 0.01, ***P < 0.001.
doi:10.1371/journal.pone.0129848.g002
Fig 3. siRNA-mediated suppression of PC expression in MDA-MB-231 cell line. Real time PCR analysis of PC mRNA expression in MDA-MB-231 cells
transfected with scrambled control (Control) or PC siRNA. The PCmRNA level was determined by Q-PCR at 48 h post-transfection (A). Western blot
analysis of PC protein in the PC knockdownMDA-MB-231 and the scrambled control (B). The statistical analysis was conducted using student’s t-test
***P 0.001.
doi:10.1371/journal.pone.0129848.g003
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Fig 4. Suppression of PC expression in MDA-MB-231 retarded proliferation both in glutamine-nourished and glutamine-depleted conditions.
MDA-MB-231 cells were transiently transfected with PC or scrambled control siRNAs. At 48 h post transfection cells were trypsinized, re-plated and grown in
the presence of 0 mM or 4 mM glutamine for 7 days. The proliferation rate of the PC knocked down (PC siRNA) and the control MDA-MB-231 cell lines
(Control) grown in the medium containing 4 mM (A) or 0 mM (C) glutamine. The relative expression of PC mRNA in the knocked down MDA-MB-231 cells
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the absence of glutamine supplementation in the medium, any anaplerotic reaction would rely
exclusively on a PC-catalyzed reaction. We generated the glutamine-independent MDA-MB-
231 cell line (Gln-) by gradually depleting glutamine from the culture medium before transfect-
ing this cell line with PCsiRNA so that the phenotype of this cell line became glutamine-inde-
pendent and PC deficient (Gln-/PC--MDA-MB-231). The Gln-/PC--MDA-MB-231cells grown
in the glutamine-free medium showed a growth rate similar to the control cell line in the first
two days but showed approximately 30–40% reduction of cell proliferation from day 3 until
day 7 (Fig 4C). Real time PCR analysis also confirmed that the retarded proliferation rate of
this cell line was accompanied by suppression of PC mRNA throughout day 7 (Fig 4D). As the
levels of PC expression were significantly correlated with the stages of cancer progression, we
hypothesized that PC was involved in the aggressive phenotypes of breast cancer cells, particu-
larly migration and invasion. We investigated whether PC was required to support migration
and invasion ability of MDA-MB-231 cells. We first examined the ability of the PC knockdown
MDA-MB-231 cells to migrate across a wound. As shown in Fig 5A and 5B, the PC knockdown
cells exhibited a 40% reduction of migration across the wound compared to the scrambled con-
trol. A similar degree of reduction was observed from the glutamine-independent PC knock-
down cell line (Fig 5C and 5D).
We next examined the ability of the knockdown cells to invade through an extracellular ma-
trix by performing an in vitro invasion assay using transwell coated with Matrigel. As shown in
Fig 6A and 6B, the PC knockdown cells showed a 40% reduction of their invasion ability. How-
ever, the reduced invasion ability was more pronounced (60%) in the glutamine-independent
knockdown MDA-MB-231 cells (Fig 6C and 6D).
We also performed similar experiments in MDA-MB-435 cells which also bear a high level
of PC protein although its migration ability is less than MDA-MB-231. Suppression of PC
mRNA expression by 80% (Fig 7A) resulted in 70% down-regulation of PC protein (Fig 7B and
7C). The PC knockdown MDA-MD-435 cells showed retarded growth rates at day 4 onwards
(Fig 7D). Suppression of PC was also associated with 40% reduction of cell migration (Fig 7E)
and 50% reduction of invasion ability (Fig 7F). Similar results were obtained when the knock-
down cells were grown in the absence of glutamine (data not shown).
Overexpression of PC in MCF-7 cells increases their proliferation and in
vitro invasion
To confirm whether overexpression of PC in breast cancer cells with low metastatic ability
would increase their proliferation rate and invasion ability, we generated stable MCF-7 cell
overexpressing PC. As shown in Fig 8A, the proliferation rate of MCF-7 cells at day 3 onward
of MCF-7 with overexpressed PC was 2-fold higher than the MCF-7 cell line transfected with
an empty vector. Similar results were observed when the MCF-7 cell line with overexpressed
PC was grown in glutamine-depleted medium (Fig 8B). It is noted that the level of endogenous
PC was slightly increased in the MCF-7 cell line harboring empty vector when these cells were
grown in the absence of glutamine, suggesting a compensatory increase of PC expression in re-
sponse to the deprivation of glutamine. MCF-7 cells with overexpressed PC also showed 2-fold
and 2.5-fold increases in the migration and invasion ability, respectively. Similar results were
obtained when the cells were assayed under glutamine-depleted medium (Fig 8C and 8D).
grown in the presence of 4 mM (B) or 0 mM (D) glutamine throughout the assay. The results are means obtained from two independent experiments, each in
triplicate. The statistical analysis was conducted using ANOVA test where *P < 0.05, **P < 0.01, ***P < 0.001.
doi:10.1371/journal.pone.0129848.g004
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Discussion
Anaplerotic reactions are important to replenish the levels of TCA cycle intermediates upon
their removal for biosynthetic purposes [9,28]. Anaplerosis via glutaminolysis is well known to
be important in many tumors as they rely on this reaction to provide precursors needed for the
Fig 5. Suppression of PC expression in MDA-MB-231 cells reducedmigration.Representative images of wound-healing assays. MDA-MB-231 cells
were transiently transfected with PC or scrambled control siRNAs. At 48 h post transfection, wound-healing assays were performed as described in the
materials and methods. (A, C) Representative images of the PC knockdown (PC siRNA) or scrambled control cells (Control) migrated across the wound
areas in the presence of 4 mM (A) or absence of glutamine (C). The wound’s closure (width) of the PC knockdown was measured and shown as the means +
standard deviation of that of the scrambled control which was arbitrarily set as 100% (B, D). The results were obtained from two independent experiments,
each in triplicate. The statistical analysis was conducted using student’s t-test where *P < 0.05.
doi:10.1371/journal.pone.0129848.g005
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syntheses of structural components, i.e. membrane lipids and nucleic acids. Disruption of glu-
tamine supply to many tumors is proposed to be one means of inhibiting their growth [29].
Anaplerosis via PC has received much attention in the past few years. Fan et al. [14] have re-
ported a high rate of pyruvate carboxylation flux as a result of overexpression of PC protein in
non-small cell lung cancer, suggesting that this cancer is highly anabolic. Overexpression of PC
in this type of cancer indicates its need to fulfill the high anabolic demands during the estab-
lishment of the primary location [14]. Cheng et al [19] have also found that PC is overex-
pressed in glioblastomas in which PC is required to support tumor growth. Subsequent studies
revealed that the presence of PC activity in glioblastomas is consistent with its anaplerotic role
Fig 6. Suppression of PC expression in MDA-MB-231 lowers invasion ability.MDA-MB-231 cells were transiently transfected with PC or scrambled
control siRNAs. At 48 h post transfection, an in vitro invasion assay was performed for 4 h in the presence of 4 mM (A) or 0 mM (C) glutamine. The number of
PC siRNA-transfected cells that invaded the transwell coated with Matrigel was counted in 5 different fields and shown as means + standard deviation in
comparison with that of the scrambled control which was arbitrarily set as 100% (B, D). The results were obtained from three independent experiments, each
done in duplicate. The statistical analysis was conducted using student’s t-test where ** P < 0.01.
doi:10.1371/journal.pone.0129848.g006
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Fig 7. Suppression of PC expression in MDA-MB-435 cells reduces their proliferation, migration and invasion. PCmRNA expression in the
knockdownMDA-MB-435 was quantitated by Q-PCR (A). Western blot analysis of MDA-MB-435 cells transfected with PC siRNA (PC siRNA) or scrambled
control (Control) (B). The band intensity of PC in B was quantitated and normalized with β-actin band and expressed as relative PC expression (C).
Proliferation assay (D), migration assay (E) and invasion assay (F) of the PC knockdown MDA-MB-435 cells. The statistical analyses in B, C, E and F were
conducted using student’s t-test while in D was conducted using ANOVA test. *P < 0.05, **P < 0.01, ***P < 0.001.
doi:10.1371/journal.pone.0129848.g007
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[30]. Furthermore, pyruvate carboxylation is also shown to be an important anaplerotic reac-
tion that contributes to the citrate pool during reductive carboxylation in osteosarcoma and
renal carcinoma cell lines [31].
Fig 8. Overexpression of PC in MCF-7 cells increases their proliferation, migration and invasion.Proliferation rate of MCF-7 cells overexpressing PC grown
in themedium containing 4mM (A) or 0 mM glutamine (B). Insets in A and B are theWestern blot analysis of MCF-7 cells transfected with empty vector (+empty,
white bars) or with overexpressed PC (+PC, black bars) at days 0, 3 and 7. MCF-7 cells overexpressing PC grown in the presence or absence of glutamine were
also subjected to migration (C) and invasion (D) assays. The statistical analysis was conducted using student’s t-test where * P < 0.05, **P < 0.01.
doi:10.1371/journal.pone.0129848.g008
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Here we show that PC is also highly expressed in breast cancer tissue but not in the normal
breast tissue. The statistical association between the levels of PC expression and the tumor size
and stage prompted us to investigate the role of this enzyme in supporting growth and inva-
sion. That expression of PC was highly abundant in two aggressive breast cancer cell lines, i.e.
MDA-MB-231 and MDA-MB-435 but low in less aggressive cell lines, i.e. MCF-7 and SKBR3
hints at the involvement of this enzyme in the aggressive phenotype of these two metastatic cell
lines. Suppression of PC expression in both MDA-MB-231 and MDA-MB-435 cells retarded
cell proliferation rate, suggesting that these cell lines modestly depend on anaplerosis via the
PC reaction. The necessity for PC in supporting growth of MDA-MB-231 cells appears to be
different from the SF-XL glioblastoma cell line which utilizes glutaminolysis rather than pyru-
vate carboxylation as the primary anaplerotic reaction [32] because suppression of PC expres-
sion does not affect its growth under glutamine-dependent conditions [15]. However, under
glutamine-depleted growth conditions, the PC-knockdown SF-XL glioblastoma cell line shows
marked reduction (>80%) of proliferation [15], indicating that the glioblastoma cell line uses
pyruvate carboxylation as an alternative route to support its growth during glutamine-depleted
conditions. However this is not the case for MDA-MB-231 and MDA-MB-435 cells because
suppression of PC expression still allows them to grow, albeit at the 50% reduced proliferation
rate observed under glutamine-dependent growth conditions. A similar but not identical phe-
notype of the PC-knockdown MDA-MB-231 and MDA-MB-435 cells was observed under glu-
tamine-independent growth conditions. An involvement of PC in the growth phenotype of
MDA-MB-231 cells is also consistent with the association between the levels of PC expression
and sizes of breast tumor in clinical samples. Low expression levels of PC in breast tumors with
a smaller size of tumor (< 4 cm3) may limit their growth compared with the larger size of tu-
mors which contain higher levels of PC expression (P< 0.05) [Table 1]. The above observa-
tions were also confirmed by overexpression of PC in MCF-7, which is a low metastatic cell
line. MCF-7 cells overexpressing PC show enhanced growth rate, motility and invasion. The
enhanced growth phenotype of MCF-7 with overexpressed PC was consistent with previous re-
ports which show that ectopic expression of PC in many mammalian cell lines enhances cell
growth and biomass production [33,34,35].
Although several studies have pointed to the importance of PC in providing oxaloacetate
which is the first TCA cycle intermediate, that in turn is converted to other precursor mole-
cules such as citrate required for lipid and nucleic acid synthesis for rapid tumor growth, not
much is known as to whether PC is required to support migration and invasion ability of some
tumors [14, 15, 19]. Our present study is the first report to show a strong association between
the levels of PC expression in breast tissues of patients and stages of cancer progression
(P< 0.05), which suggests PC is involved in metastasis. This was also studied in MDA-MB-
231 and MDA-MB-435 cells. Suppression of expression of PC markedly reduced both migra-
tion and invasion ability through an extracellular matrix under both glutamine-nourished and
glutamine-depleted conditions, suggesting that PC is required to support these aggressive phe-
notypes of MDA-MB-231 cells. The negative staining of PC expression by immunohistochem-
istry in the normal area of breast tissue is consistent with the low level of expression of PC in
the MCF-7 cell line. The transcriptional mechanism underlying overexpression of PC in
MDA-MB-231 over MCF-7 is due to the selective activation of the distal rather than the proxi-
mal promoter of the human PC gene (Fig 2C). The specific transcription of the distal rather
than the proximal promoter of the human PC gene may be attributed to the presence of differ-
ent putative transcription factor binding sites of both promoters [24] during the transition of a
low to a high metastatic phenotype. Interestingly, Lee et al. (2012) have shown that the MCF-7
cells stimulated with Wnt 1 or Wnt3a ligands, or ectopically expressed with Snail, a target tran-
scription factor of Wnt signaling, show a marked increase in PC expression. Because the Wnt
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signaling pathway also induces Snail-dependent epithelial-mesenchymal transition (EMT),
which is responsible for invasion and metastasis in many tumors [36,37], the authors suggest
that anaplerosis via up-regulation of PC expression is one of several metabolic responses of
breast tumor during EMT [38]. Although this study underscores that the Wnt signaling path-
way is important for transcriptional induction of the PC gene, the authors cannot detect direct
binding of Snail, an effector transcription factor in response to Wnt signaling to the distal pro-
moter of human PC gene [38].
Although the involvement of PC with migration and in vitro invasion of MDA-MB-231
cells per se is yet to be elucidated, it is apparent that migration of the tumors from the primary
location to the distal organs during metastasis requires multiple biological steps such as intra-
vasation into the circulation, followed by migration, extravasation to a second site for adhesion,
tumorigenesis and angiogenesis [39], all of which require substantial amounts of ATP to pro-
vide a source of energy [40]. This is consistent with the findings that metastasized tumors in-
cluding breast and osteosarcoma show up-regulation of energy generating pathways including
TCA cycle activity and nucleotide metabolism [40,41,42]. As PC provides oxaloacetate, the
first intermediate in the TCA cycle, disruption of oxaloacetate supply by suppressing PC ex-
pression may disrupt the continual supply of this intermediate required for oxidation of pyru-
vate hence lowering ATP production required to support cell movement. Although many
tumors are highly glycolytic, growing evidence have shown that highly metastasized tumors
also utilize mitochondria to oxidize glucose. In ovarian cancer and possibly breast cancer
[43,44], the metastasized tumor invades the adjacent adipose tissue to hijack lipids to use as an
alternative fuel apart from glucose to support tumor growth and invasion. Since β-oxidation of
fatty acids produces large amounts of acetyl-CoA which is subsequently oxidized via the con-
densation with oxaloacetate in the TCA cycle, a high abundance of PC would ensure that oxa-
loacetate is not limited during β-oxidation of the hijacked lipids. The presence of PC may be
involved in gluconeogenesis. Leithner et al [45] have recently shown that lung cancer utilizes
gluconeogenesis to recycle lactate back to glucose as an adaptive metabolic response to glucose
depletion. This was born out by the observation of overexpression of mitochondrial phospho-
enolpyruvate carboxykinase (PEPCK-M), one of four gluconeogenic enzymes concomitant
with the increased flux of lactate to phosphoenolpyruvate. However, the level of PC expression
varied in the three lung cancers examined in this study and was not up-regulated by low
glucose concentrations.
Other possible roles of PC in supporting breast cancer growth and metastasis may be linked
to the metabolic coupling factor, NADPH. In pancreatic β-cells, PC is highly abundant to sup-
port the high activity of pyruvate cycling which provides a large amount of NADPH, required
for glucose-induced insulin secretion [46]. In tumors, it is possible that the similar pyruvate/
malate shuttle [47,48,49] may operate in the similar manner as in the pancreatic islet. Several
lines of evidence have suggested that NADPHmay be a key molecule which links between reac-
tive oxygen species (ROS) formation and the EMT via the overexpression of NADPH oxidase,
notably the NOX4 isoform which is overexpressed in many tumors [50,51]. NOX4 is known to
mediate the production of ROS which triggers cellular senescence, resistance to apoptosis and
tumorigenic transformation [52].
The lack of statistical association between expression of PC and ER as well as PR and HER2
in cancer breast tissues indicates that PC is not regulated by these hormones or growth factor.
This is also consistent with the phenotypes of MCF-7 and MDA-MB-231 cells which are ER+
and ER-, respectively [53].
In summary we have shown that PC is expressed in breast cancer at a higher level than in
the normal breast tissue, and exhibits a statistical association with tumor size and the progres-
sion of metastasis. Using the highly metastatic breast cancer cell lines, MDA-MB-231 and
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MDA-MB-435 as models, we showed that suppression of PC expression markedly reduces the
proliferation, migration and in vitro invasion ability of cells, highlighting the possible roles of
PC in supporting these processes during oncogenesis and progression of breast cancer.
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